# Timolol Maleate Gel for the Treatment of Infantile Hemangioma

> **NCT06677853** · PHASE2,PHASE3 · COMPLETED · sponsor: **Auson Pharmaceuticals Inc.** · enrollment: 168 (actual)

## Conditions studied

- Infantile Hemangioma

## Interventions

- **DRUG:** Timolol Maleate Gel+Placebo
- **DRUG:** Timolol Maleate Gel
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06677853
- **Lead sponsor:** Auson Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-28
- **Primary completion:** 2022-06-21
- **Final completion:** 2022-06-21
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06677853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06677853, "Timolol Maleate Gel for the Treatment of Infantile Hemangioma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06677853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*